Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence imaging capabilities. It is best suited for high-content screening (HCS) and ...

Time-resolved fluorescence resonance energy transfer (TR-FRET) combines fluorescence detection with temporal resolution to significantly enhance assay performance. This technology minimizes background ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for ...

A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...

Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making ...

The "High Content Screening/Imaging: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The High Content Screening/Imaging Market was valued at USD 3.4 ...